Prescribing costs: Whose responsibility?

D. Henry*

*Corresponding author for this work

Research output: Contribution to journalEditorialResearch

4 Citations (Scopus)


Australia's spending on the Pharmaceutical Benefits Scheme (PBS) is growing at a rate of approximately 10-15% annually. Is this important, why is it happening, and can we learn lessons from the papers published in this issue of Australian Prescriber?

Prescribing costs are important. As total health spending in this country is capped, the extra money for drugs has to be found elsewhere. Each year we spend approximately $300 million more on drugs than we did in the previous year. This is equivalent to the annual operating costs of two moderate-sized teaching hospitals. Consequently, we have to ask if the money could be better spent elsewhere.
Original languageEnglish
Pages (from-to)26-27
Number of pages2
JournalAustralian Prescriber
Issue number2
Publication statusPublished - 1997
Externally publishedYes


Dive into the research topics of 'Prescribing costs: Whose responsibility?'. Together they form a unique fingerprint.

Cite this